Literature DB >> 10491120

Mapping of an epitope recognized by a neutralizing monoclonal antibody specific to toxin Cn2 from the scorpion Centruroides noxius, using discontinuous synthetic peptides.

E S Calderon-Aranda1, B Selisko, E J York, G B Gurrola, J M Stewart, L D Possani.   

Abstract

The Na+-channel-affecting toxin Cn2 represents the major and one of the most toxic components of the venom of the Mexican scorpion Centruroides noxius Hoffmann. A monoclonal antibody BCF2 raised against Cn2 has been shown previously to be able to neutralize the toxic effect of Cn2 and of the whole venom of C. noxius. In the present study the epitope was mapped to a surface region comprising the N- and C-terminal segments of Cn2, using continuous and discontinuous synthetic peptides, designed on the basis of the sequence and a three-dimensional model of Cn2. The study of peptides of varying length resulted in the identification of segments 5-14 and 56-65 containing residues essential for recognition by BCF2. The peptide (abbreviated SP7) with the highest affinity to BCF2 (IC50 = 5.1 microM) was a synthetic heterodimer comprising the amino acid sequence from position 3-15 (amidated) of Cn2, bridged by disulfide to peptide from position 54-66, acetylated and amidated. Similar affinity was found with peptide SP1 [heterodimer comprising residues 1-14 (amidated) of Cn2, bridged with synthetic peptide 52-66 (acetylated)]. SP1 and SP7 were used to induce anti-peptide antibodies in mouse and rabbit. Both peptides were highly immunogenic. The sera obtained were able to recognize Cn2 and to neutralize Cn2 in vitro. The most efficient protection (8.3 microgram Cn2 neutralized per mL of serum) was induced by rabbit anti-SP1 serum.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10491120     DOI: 10.1046/j.1432-1327.1999.00620.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  Arsenic exposure and human papillomavirus response in non-melanoma skin cancer Mexican patients: a pilot study.

Authors:  J Alberto Rosales-Castillo; Leonor C Acosta-Saavedra; Rosantina Torres; Jesús Ochoa-Fierro; Víctor H Borja-Aburto; Lizbeth Lopez-Carrillo; Gonzalo G Garcia-Vargas; Georgina B Gurrola; Mariano E Cebrian; Emma S Calderón-Aranda
Journal:  Int Arch Occup Environ Health       Date:  2004-07-03       Impact factor: 3.015

Review 2.  Scorpions from Mexico: From Species Diversity to Venom Complexity.

Authors:  Carlos E Santibáñez-López; Oscar F Francke; Carolina Ureta; Lourival D Possani
Journal:  Toxins (Basel)       Date:  2015-12-24       Impact factor: 4.546

Review 3.  Innovative Immunization Strategies for Antivenom Development.

Authors:  Erick Bermúdez-Méndez; Albert Fuglsang-Madsen; Sofie Føns; Bruno Lomonte; José María Gutiérrez; Andreas Hougaard Laustsen
Journal:  Toxins (Basel)       Date:  2018-11-02       Impact factor: 4.546

4.  Synthetic peptides to produce antivenoms against the Cys-rich toxins of arachnids.

Authors:  Silvia A Camperi; Gerardo Acosta; Gabriela R Barredo; Lucía C Iglesias-García; Cleópatra Alves da Silva Caldeira; María C Martínez-Ceron; Silvana L Giudicessi; Osvaldo Cascone; Fernando Albericio
Journal:  Toxicon X       Date:  2020-05-05

5.  Heterologous expression of four recombinant toxins from Panamanian scorpions of the genus Tityus and Centruroides for production of antivenom.

Authors:  Marcos H Salazar; Herlinda Clement; Ligia L Corrales-García; Jairo Sánchez; John Cleghorn; Fernando Zamudio; Lourival D Possani; Hildaura Acosta; Gerardo Corzo
Journal:  Toxicon X       Date:  2021-12-28

Review 6.  Biotechnological Trends in Spider and Scorpion Antivenom Development.

Authors:  Andreas Hougaard Laustsen; Mireia Solà; Emma Christine Jappe; Saioa Oscoz; Line Præst Lauridsen; Mikael Engmark
Journal:  Toxins (Basel)       Date:  2016-07-23       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.